Nanomedicine News

RSS

Nanovesicles to Combat Multiple Cancer Cells

Bexion Pharmaceuticals has received the Biotech Innovation Award at the Cincinnati USA Innovation Awards program hosted by the Cincinnati Business Courier, the Cincinnati USA Regional Chamber and CincyTech.

21 Apr 2011

Rat skin and Artificial Human Skin Treated with Generic Skin Cream Exhibit Similar Responses on Microscopic Scales

A research team at the Ohio State University discovered that both rat skin and artificial human skin when treated with a generic skin cream exhibited the same responses on microscopic scales. This discovery could prove beneficial in treating burn victims.

21 Apr 2011

Targeting Light-Sensitive Molecules to Tumor Site Ensures Effective Treatment

A team of researchers from the University of Hull and ETH Zurich connected light-sensitive molecules to antibodies that target blood vessels in tumors.

20 Apr 2011

Material Composition and Nanoparticle size help Reduce Biofilm Creation

ULURU showcased and presented a paper at the recently concluded Symposium on Advances in Skin and Wound Care and Wound Healing Society, which was held in Dallas.

20 Apr 2011

Nano-Contrast Agents, Single Domain Antibodies Will Lead to Faster and Effective Cancer Treatment

A team of researchers ed by professor Dar-Bin Shieh of Institute of Oral Medicine in Medical College at the National Cheng Kung University has collaborated with scientists led by Dr. Dennis Whitefield from National Research Council of Canada to create cancer diagnostic and therapy technologies.

20 Apr 2011

Shrink Nanotechnologies Applies for Patent certification for its Cell Align Product Portfolio and Immunoassay Substrate

Shrink Nanotechnologies has applied to the US Patent & Trademark Office for certification of its Cell Align, cell culturing and tissue engineering material, and a immunoassay substrate.

20 Apr 2011

DermaVir Employs Nanotechnology to boost Patient’s Immunity to Destroy HIV-infected cells

Power of the Dream Ventures, a Hungarian company that acquires and develops technologies, recently declared Phase II test results by Genetic Immunity of its Lead Product called DermaVir, based on an earlier contract. ...

20 Apr 2011

Nanotechnology-based Platforms to Deliver Essential Vitamins to Diseased Cells

Access Pharmaceuticals is collaborating with a pharmaceutical company to use its CobaCyte and CobOral technology to deliver RNAi therapeutics.

From Abeona Therapeutics Inc. 20 Apr 2011

Nanobodies Likely to Treat Individual Cancer Types

A new breakthrough published online in The FASEB Journal could enable doctors identify patients who could respond to breast cancer drug treatments.

20 Apr 2011

Lipid-based Nanoparticles Could Reduce Gastrointestinal Toxicity

The Centre for Drug Research and Development (CDRD) and the BC Cancer Agency (BCCA) have declared that Champions Oncology has used an option to license Irinophore C, a liposomal formulation of Irinotecan.

20 Apr 2011